The mean absolute change from baseline in inflammatory lesion counts was -18.1, -14.6, and -11.2 in the Emrosi, doxycycline, and placebo arms, respectively. The most common adverse reaction reported ...

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating ...

House of Representatives Deputy Majority Leader Erwin Tulfo and ACT-CIS party-list on Wednesday donated 50 boxes, or 5,000 ...

Cannabidiol (CBD) capsules are easy to use and can provide more consistent dosing than oils because each dose is premeasured. However, unlike CBD oils, CBD capsules are subject to the first-pass ...

(AP) — Four astronauts returned to Earth on Friday after a nearly eight-month space station stay extended by Boeing’s capsule trouble and Hurricane Milton. A SpaceX capsule carrying the crew ...

Journey Medical (DERM) presented data assessing the dermal and systemic pharmacokinetics of oral DFD-29 versus oral Doxycycline 40 mg capsules in healthy subjects at the 44th Fall Clinical ...

Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral Doxycycline 40 mg Capsules (Oracea®) in Healthy ...

Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral Doxycycline 40 mg Capsules (Oracea®) in Healthy ...

The SpaceX Dragon capsule carrying the four-member crew splashed down off the coast of Pensacola, Fla., just before 3:30 a.m. ET after a fiery nighttime return across southern Mexico. Over about an ...